AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 20 filers reported holding AMBRX BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,331,951 | +6.5% | 1,027,291 | -49.3% | 0.01% | +20.0% |
| Q3 2022 | $2,189,000 | -59.3% | 2,027,291 | 0.0% | 0.01% | -58.3% |
| Q2 2022 | $5,372,000 | -35.7% | 2,027,291 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $8,352,000 | -51.9% | 2,027,291 | +5.4% | 0.02% | -48.4% |
| Q4 2021 | $17,371,000 | -29.6% | 1,923,700 | +5.3% | 0.03% | -36.7% |
| Q3 2021 | $24,668,000 | -31.1% | 1,827,292 | 0.0% | 0.05% | -30.0% |
| Q2 2021 | $35,815,000 | – | 1,827,292 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 11,304,573 | $100,836,791 | 27.58% |
| COMMODORE CAPITAL LP | 4,803,447 | $42,846,747 | 6.52% |
| VR Adviser, LLC | 3,298,577 | $29,423,307 | 5.74% |
| Cormorant Asset Management, LP | 8,500,000 | $75,820 | 4.99% |
| Ghost Tree Capital, LLC | 250,000 | $2,230,000 | 0.66% |
| TOMS Capital Investment Management LP | 1,000,000 | $8,920,000 | 0.55% |
| Artal Group S.A. | 702,291 | $6,264 | 0.37% |
| Fosun International Ltd | 249,190 | $2,222,775 | 0.21% |
| D. E. Shaw & Co., Inc. | 3,933,552 | $35,087,284 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 361,000 | $3,220,120 | 0.02% |